Results 91 to 100 of about 56,752 (229)

Intraoperative 40 Hz Visual Light Flicker Attenuates Anesthesia/Surgery‐Induced Cognitive Impairments in Elderly Mice With Enhanced Cortical‐Hippocampal Coherence

open access: yesCNS Neuroscience &Therapeutics, Volume 32, Issue 3, March 2026.
Light flicker activated the visual cortex intraoperatively, including: a reduction in electrical activity suppression, and enhancement of high‐frequency gamma wave power. Moreover, its effects extended beyond the visual cortex, reversing the decline in gamma frequency coherence between the visual cortex and hippocampus and maintaining functional ...
Jingyao Jiang   +12 more
wiley   +1 more source

Extent and Incidence of Pseudo‐Worsening of Kidney Function Due to Oral Antitumor Therapeutics in the AMBORA Cohort: An Analysis of Real‐World Data

open access: yesClinical Pharmacology &Therapeutics, Volume 119, Issue 3, Page 802-811, March 2026.
A considerable number of oral antitumor therapeutics (OAT) has the potential for causing pseudo‐worsening of kidney function (PW) due to inhibition of renal creatinine secretion, i.e., kidney function is unaffected, while creatinine‐based calculation of glomerular filtration rate (eGFR) erroneously indicates an impaired kidney function.
Michael I. Sponfeldner   +13 more
wiley   +1 more source

A Case of Cytokine Release Syndrome Induced by Avelumab and Axitinib Combination Therapy for Metastatic Renal Cell Carcinoma

open access: yesIJU Case Reports, Volume 9, Issue 2, March 2026.
ABSTRACT Introduction Cytokine release syndrome (CRS) is a rare immune‐related adverse event of immune checkpoint inhibitors (ICIs). At present, its association with avelumab–axitinib therapy for renal cell carcinoma (RCC) has yet to be reported. Differentiating early CRS from an infusion‐related reaction (IRR) is clinically challenging, particularly ...
Rio Shibata   +7 more
wiley   +1 more source

Laparoscopic right radical nephrectomy for locally advanced renal tumor: Case report

open access: yesActa Marisiensis - Seria Medica
Renal cell carcinoma (RCC) represents the most common solid malignancy of the kidney, comprising a broad spectrum of histopathological entities. Advances in diagnostic imaging, histopathological classification, and minimally invasive surgical techniques ...
Vascul Rares Florin   +8 more
doaj   +1 more source

Successful Treatment of Paranasal Sinus Metastasis From Renal Cell Carcinoma With Immune Checkpoint Inhibitors and Radiotherapy: A Case Report

open access: yesIJU Case Reports, Volume 9, Issue 2, March 2026.
ABSTRACT Introduction Renal cell carcinoma (RCC) metastasis to the paranasal sinuses is rare and lacks standard treatment, particularly for unresectable tumors. We report a case of sphenoid sinus metastasis with sarcomatoid differentiation successfully managed with radiation therapy and immunotherapy.
Shota Yamada   +7 more
wiley   +1 more source

Nephrectomy

open access: yesAORN Journal, 2017
Benjamin T. Waldorf, David Canes
  +5 more sources

A Case of Reactive Lymphoid Hyperplasia That Is Difficult to Differentiate From Renal Cancer With Lymph Node Metastasis

open access: yesIJU Case Reports, Volume 9, Issue 2, March 2026.
ABSTRACT Introduction Reactive lymphoid hyperplasia (RLH) is a rare benign lymphoproliferative disorder that rarely involves the kidney and has not been reported in association with regional lymphadenopathy. Case Presentation A 70‐year‐old woman was incidentally found to have a left renal mass.
Shunki Nakagawa   +9 more
wiley   +1 more source

Inferior Vena Cava Thrombosis After Nephrectomy of the Native Kidneys in Patients With Autosomal Dominant Polycystic Kidney Disease

open access: yesIJU Case Reports, Volume 9, Issue 2, March 2026.
ABSTRACT Background Inferior vena cava (IVC) thrombosis associated with autosomal dominant polycystic kidney disease (ADPKD), caused by mechanical compression from a large liver or renal cysts, has previously been reported. However, postoperative thrombosis following nephrectomy of the native kidneys has not been described.
Yuto Matsushita   +9 more
wiley   +1 more source

A Case of Renal Cell Carcinoma With Inferior Vena Cava Tumor Thrombus Achieving Pathologic Complete Response Following Combination Therapy With Lenvatinib and Pembrolizumab

open access: yesIJU Case Reports, Volume 9, Issue 2, March 2026.
ABSTRACT Introduction The efficacy of neoadjuvant lenvatinib plus pembrolizumab for clear cell renal cell carcinoma with inferior vena cava tumor thrombus remains unclear. Case Presentation An 80‐year‐old man was diagnosed with clear cell renal cell carcinoma and tumor thrombus extending into the inferior vena cava.
Hiroki Takayama   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy